- Home
- ADSE vs BVS Comparison
ADSE vs BVS Comparison
Compare ADSE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- BVS
- Stock Information
- Founded
- ADSE 1980
- BVS 2011
- Country
- ADSE Ireland
- BVS United States
- Employees
- ADSE N/A
- BVS N/A
- Industry
- ADSE Industrial Specialties
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADSE Consumer Discretionary
- BVS Health Care
- Exchange
- ADSE Nasdaq
- BVS Nasdaq
- Market Cap
- ADSE 580.7M
- BVS 476.3M
- IPO Year
- ADSE N/A
- BVS 2021
- Fundamental
- Price
- ADSE $10.27
- BVS $7.46
- Analyst Decision
- ADSE
- BVS Strong Buy
- Analyst Count
- ADSE 0
- BVS 4
- Target Price
- ADSE N/A
- BVS $13.75
- AVG Volume (30 Days)
- ADSE 86.3K
- BVS 327.5K
- Earning Date
- ADSE 12-23-2025
- BVS 11-04-2025
- Dividend Yield
- ADSE N/A
- BVS N/A
- EPS Growth
- ADSE N/A
- BVS N/A
- EPS
- ADSE N/A
- BVS 0.15
- Revenue
- ADSE $53,275,396.00
- BVS $563,829,000.00
- Revenue This Year
- ADSE $219.58
- BVS N/A
- Revenue Next Year
- ADSE N/A
- BVS $7.22
- P/E Ratio
- ADSE N/A
- BVS $48.51
- Revenue Growth
- ADSE N/A
- BVS 1.58
- 52 Week Low
- ADSE $7.89
- BVS $5.81
- 52 Week High
- ADSE $16.35
- BVS $12.61
- Technical
- Relative Strength Index (RSI)
- ADSE 48.88
- BVS 60.28
- Support Level
- ADSE $9.20
- BVS $7.22
- Resistance Level
- ADSE $10.91
- BVS $8.23
- Average True Range (ATR)
- ADSE 0.73
- BVS 0.34
- MACD
- ADSE -0.00
- BVS 0.08
- Stochastic Oscillator
- ADSE 41.70
- BVS 54.91
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.